I get the feeling he had another sentence in there and decided to delete it. So something like - I'm disappointed you think the Chair's sale ...
It may be that his responses are vetted by a PR person within the company.
All just guesses.
Printable View
Balance....If you take the opposite tack,could not the big sellers like the Masfen's just be sitting there blasting away when your punters (traders) start trying to push the price.This selling has been going on for weeks.The only time it rises out of the band seems to be when their broker has gone for a coffee......cheers.
goldie - you might be interested in this article
even if you don't read as 'are we in a bubble' it is a good insight into what drives biotech prices, both mature companies to ones just starting to generate +ve cash flows
http://www.mauldineconomics.com/outs...biotech-bubble
Thanks very much for the article - a really interesting read.
Hi all, I know we're expecting reporting in May some time but does anyone know the specific date? Thanks in advance. SD
NBI down 1.88% PEB held up pretty well the other day when NBI was down .66% but (dare I say it)this could be a test.
Thanks psychic. So either the ODT got it wrong or misinterpreted a comment, (despite their denials) or the Chairman got carried away and made a comment that had no basis. Either way, I cant see it's an issue except if its the latter, someone needs to have a conversation with the Chairman.
The "I'm disapointed" comment comes after the sales by the chair comment. DD obviously dissapointed that the chair was selling.
The end ( and good) result is a pending regular lab throughput report which should remove a heck of a lot of speculation and with any luck reduce considerably the number of less than useful posts on this thread!
Noah fence meant.
If the chairman does not have knowledge re the penetration rate I think it's about time he looked into it, IMO
the chairman should be updated at least monthly. As shareholders of this company we all own small bits of the business and management are our employees and have a duty to protect the investors funds, inform investors regularly and hopefully increase it's value.
I'm sure the like's of Masfen's get the information they require to insure there funds invested are being looked after. It's good to hear we might look forward to quarterly results, As a growth company Peb can not be faulted now we need to see how management will take over from the scientists and turn this into a cash cow.
Or as New Guy so eloquently put it Show us the ******* sales.